The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks Mixed Ahead Of Johnson's Brexit Deal Vote

Fri, 20th Dec 2019 12:09

(Alliance News) - Stocks in London were mixed at midday on Friday as investors look ahead to the Brexit deal vote in Parliament in the afternoon, while the UK chancellor finally named a new governor of the Bank of England.

The FTSE 100 index was up 16.90 points, or 0.2% at 7,589.97. The mid-cap FTSE 250 index was down 60.96 points, or 0.3% at 21,605.18, and the AIM All-Share index was 0.4% higher at 941.63.

The Cboe UK 100 index was up 0.2% at 12,865.61. The Cboe 250 was 0.2% lower at 19,518.94, and the Cboe Small Companies was down 0.2% at 12,030.27.

In mainland Europe, the CAC 40 in Paris was up 0.5% and the DAX 30 in Frankfurt was up 0.6%.

"UK stocks are treading water as they eagerly await the next step in the Brexit process today. With Theresa May and Boris Johnson previously unable to pass their respective withdrawal agreements, the value of a strong parliamentary majority will become clear today as Johnson's deal looks set to sail through without a hitch. For markets this should provide some degree of certainty and confidence, yet we are instead seeing anxiety remain thanks to Johnson's hard deadline of December 2020 to conclude trade negotiations," said IG Group's Josh Mahony.

In the FTSE 100, AstraZeneca was up 1.5% after the Anglo-Swedish drugmaker said it divested the rights to cancer drugs Arimidex and Casodex in a number of countries to Juvise Pharmaceuticals for up to USD198 million.

At the other end of the large cap index, NMC Health was by far the worst performer, down 21%. The Financial Times on Friday reported the UAE-focused private healthcare firm held talks to raise EUR200 million of off-balance sheet debt to fund new hospitals.

NMC has come under increased scrutiny from analysts, investors and short-sellers this year about its apparent use of off-balance sheet financing, that does not count toward its official debt levels.

NMC shares dropped on Tuesday after short selling firm Muddy Waters Capital said it had shorted the stock, commenting: "We have serious doubts about the company's financial statements, including its asset values, cash balance, reported profit, and reported debt levels."

NMC on Thursday hit back saying the Muddy Waters report was "false" and "misleading".

NMC shares have almost halved in value this week.

Royal Dutch Shell 'A' and 'B' shares were down 1.2% on Friday, after the oil major guided for a potential impairment based on "the macro outlook".

Shell is to book a post-tax impairment of USD1.7 billion to USD2.3 billion for the fourth-quarter of 2019, based on macroeconomic conditions, without giving any further details. The oil giant, London's largest listed company by market capitalisation, guided for a number of other charges which are set to hit fourth-quarter earnings.

In the Upstream unit, Shell will book USD100 million to USD200 million in charges related to well write-offs, plus a USD500 million to USD600 million deferred tax charge. Production in the segment for the last quarter of 2019 is guided between 2.78 million and 2.83 million barrels of oil equivalent per day. Production in all of 2018 was around 2.7 million barrels a day.

Still to come in the UK corporate calendar, Anglo-US cruise line operator Carnival is expected to report annual earnings this afternoon.

The pound was quoted at USD1.3035 at midday, slightly higher than USD1.3015 late Thursday, after UK economic growth in the third-quarter was revised upwards, the Office for National Statistics revealed.

Third-quarter gross domestic product expanded 0.4% from the second quarter, the ONS said, having previously reported a quarter-on-quarter figure of 0.3%. The ONS also reported a higher annual growth figure, with GDP in the third quarter rising by 1.1% compared to the prior estimate of 1.0%. Services remain the main contributor to growth, the ONS said, with construction also contributing positively.

Meanwhile, the head of the UK financial watchdog Andrew Bailey has been chosen as the next governor of the Bank of England, the Treasury announced.

Bailey's tenure at the BoE will begin on March 16 next year and will succeed Canadian Mark Carney, who took up the role in 2013. Carney has since extended his tenure twice, the second time to avoid any disruption during the UK's talks to leave the EU.

Bailey has been head of the Financial Conduct Authority since July 2016. Before that, he was chief executive of the Prudential Regulation Authority.

As part of his general election pledge to have Brexit "decided" by Christmas, UK Prime Minister Boris Johnson will bring back the EU Withdrawal Agreement Bill for its second reading in the House of Commons on Friday.

After the Conservatives won a landslide at the general election and secured an 80-seat majority last week, the vote in the afternoon is expected to pass without a hitch for the government and lay the ground for a January exit from the EU.

The euro stood at USD1.1094 at midday, down from USD1.1111 late Thursday. Against the yen, the dollar was trading at JPY109.35, firm from JPY109.28 late Thursday.

Stocks in New York were set for a subdued open on Friday. All three major US stock indices set fresh highs on Thursday amid a cooling of US-China trade tensions and a new continental trade agreement among the US, Canada and Mexico advancing in Congress.

The DJIA was called called up 0.1%, the S&P 500 index called flat and the Nasdaq Composite up 0.1%.

Ahead in the economic events calendar, there are US third-quarter GDP figures at 1330 GMT.

Brent oil was quoted at USD66.22 a barrel at the equities close, soft against USD66.50 late Thursday.

Gold was quoted at USD1,477.30 an ounce at the London equities close, little changed USD1,476.20 late Thursday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

London market Midday is available to subscribers as an email newsletter. Contact info@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.